Masimo
Irvine patient monitoring company founded in 1989, known for motion-tolerant pulse oximetry.
Masimo’s signal extraction technology addressed a specific clinical failure — pulse oximeters losing accuracy when a patient moved or had poor perfusion, exactly the situations where the reading matters most.
Selling into hospitals
Device purchasing runs through value analysis committees, not individual clinicians. Trade show conversations are as much about evidence and total cost as they are about the technology.